Abstract
(Anesth Analg. 2015;120:1074–1084) Uterine atony is the leading cause of postpartum hemorrhage (PPH) worldwide, and is responsible for 35% of maternal mortality. Oxytocin is currently the most commonly used drug for uterotonic therapy. Other drugs, such as ergonovine and carboprost can also be used when oxytocin has failed to improve uterine tone. The authors of this study compared the ability of both high and low doses of oxytocin versus ergonovine or carboprost, to contract myometrial muscle obtained from women undergoing cesarean delivery. They also investigated the effect that oxytocin pretreatment had on the contractile effect.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
